|
|
|
|
Summer Brings Sunshine, New Companies and New Instruments To Our Cores!
|
|
Golden Ticket
Eisai Innovation, Inc. and MBC BioLabs announce the 2023 Eisai Golden Ticket Competition to pursue early drug discovery and research efforts. Eisai is interested in drug discovery technologies, novel targets & biology that can be utilized in oncology and neurology.
► APPLY
|
|
|
Our New Partnership with Cell Microsystems Brings the CellRaft Air To The Core
Find out how the Cellraft Air's technology helped Uli from Engage Bio successfully isolate rare cells (1% in parental cell population) and get growing monoclonal cell populations within 1.5 weeks!
► LEARN MORE
|
|
|
Introducing the Thermofisher Absolute Q
New instrument alert! We are excited to have the Absolute Q - a system that simplifies and automates digital PCR - located in our cores!
► LEARN MORE
|
|
|
JLABS Summer BBQ Bash
August 23 @ 11am - 1pm
953 Indiana St, San Francisco
Summer isn't complete without some front yard BBQ! Please join us and our wonderful partners at JLABS for a BBQ Bash!
► REGISTER
|
|
|
Partner Office Hours
Looking to connect with Sartorius, Agilent, Revvity, or Thermo Fisher Scientific - and enjoy a free treat? Check times and locations on our Partner calendar.
► CHECK THE CALENDAR
|
|
|
Integrated Biosciences Announces Synthetic Biology Platform Enabling Control Over Aging-Associated Stress Response
► READ MORE
|
|
|
EpiBiologics Hires Former Genentech, Altos Labs Executive As New CEO
► READ MORE
|
|
|
MBC BioLabs Alumni in The 20 (+2) Under 40 List
Maria Soloveychik, CEO of Synthex and Kevin Parker, CEO of Cartography Biosciences made this year's 20 Under 40 List. Congratulations Maria and Kevin on this well-deserved recognition!
► READ MORE
|
|
|
Nscrpt
ncrspt is a DNA engineering platform that utilizes a combinatorial approach to enhance the efficiency and scalability of DNA editing. By integrating synthetic biology with targeted gene editing, our platform has the potential to revolutionize not only biopharmaceuticals/ biotechnology, but also other industries such as oil and gas, cosmetics, and more, with the potential to generate products with a market value exceeding $2 trillion. ncrspt's platform can create products at scale, serving as a foundation for developing tailor-made products. In addition to non-profit organizations and academia, ncrspt's initial customers include corporations, intelligence agencies, and governments from Western countries.
|
|
|
Humanity Neurotech
Humanity Neurotech is developing a magnetic field intervention to reduce inflammation in the brain. Applications include traumatic brain injury, Long Covid, and several other neurological and psychiatric diseases linked to brain inflammation.
|
|
|
b.next
b.next provides on-demand design and construction of fully-defined, programmable cellular systems to help solve now-difficult or impossible biotechnology challenges.
|
|
|
inTUMO Therapeutics
inTUMO Therapeutics' mission is to transform cancer care with improved locoregional treatment. We offer a solution to treating solid tumors that are difficult or dangerous to treat through existing products/procedures and in a patient population that doesn't have a standard of care. inTUMO's product is percutaneously injected into solid tumors through an out-patient image guided procedure and will result in tumor ablation within a few hours. Our initial focus is on prostate and liver tumors.
|
|
|
|
SPECIAL THANKS TO OUR PARTNERS
|
|
|
|
|
|
|
|
MBC BioLabs - Enabling Awesome
|
|
|
|
|
|
|
